HCW Biologics HCWB
NASDAQ HCWB
$2.18 +0.06 (+2.83%)
At close: Aug 21, 2026 · 4:00 PM EDT

HCW Biologics (HCWB) Non Operating Income (2024)

HCW Biologics' (HCWB) quarterly Non Operating Income came in at -$1.3 million in Q2 2024.

HCW Biologics (HCWB) Non Operating Income (2024) Analysis & Trends

HCW Biologics (HCWB) has 1 years of Non Operating Income data on file, last reported at -$1.3 million in Q2 2024.

  • Quarterly Non Operating Income changed N/A year-over-year to -$1.3 million in Q2 2024, while the trailing twelve-month figure through Jun 2025 was -$1.3 million (changed N/A YoY) and the FY2024 annual result came in at -$1.3 million, changed N/A from the prior year.
  • Non Operating Income held at -$1.3 million in Q2 2024.
  • In the past five years, Non Operating Income ranged from a high of -$1.3 million in Q2 2024 to a low of -$1.3 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 234.30 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -53.64 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -51.63 Mn
10 HCW Biologics 2.86 Mn 2.11 Mn -93,887.00 -

Historic Data

Download Data
DateValue
Jun 30, 2024 -1.30 Mn